The Google Pixel 9a is the company's newest mid-range Android smartphone. Part of the A-series, the Pixel 9a continues the tradition of being the most affordable offering in the latest generation ...

Following the Pixel 9a launch, Google will focus on the next version of Android and the upcoming Pixel 10 and Pixel 10 Pro family. This weekend saw its hardware and software strands cross over ...

The Pixel 9a now has an official release date. According to Google, the Pixel 9a will finally hit store shelves in the U.S., Canada, and UK on April 10. Google officially announced the Pixel 9a ...

As I gathered my thoughts for this Google Pixel 9a review, I struggled to come up with things I didn’t like about it. For a $500 “budget” phone, it has the nicest Pixel design to date ...

The Google Pixel lineup of smartphones is one of the best and most popular out there alongside the Apple iPhone and Samsung Galaxy lineups. Over the years, Google has cemented the Pixel as one of ...

After a last-minute delay, Google today announced that Pixel 9a will launch starting April 10. The Pixel 9a was originally expected to hit store shelves earlier this week. However, Google delayed ...

Today we have with us Google's latest smartphone, the Pixel 9a. As with the other A-series devices, this is to become the most affordable model in the current generation Pixel lineup and starts at ...

The wait for the Google Pixel 9a will soon be over. After announcing its new midrange phone earlier this month, Google has set official Pixel 9a release dates depending on where you are in the world.

USCIS received enough petitions to meet the H-2B statutory cap for the second half of fiscal year 2025. (Bloomberg) U.S. Citizenship and Immigration Services (USCIS) has received enough petitions ...

The federal government announced that it is freezing $2.2 billion in grants and $60 million in contracts to Harvard University after the school rejected the Trump administration's demands to ...

Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to jointly develop and commercialize an experimental heart disease ...